European Medicines Agency recommends eliminating medicines with tetrazepam

2013/04/30 Galarraga Aiestaran, Ana - Elhuyar Zientzia Iturria: Elhuyar aldizkaria

• Medikuntza
• Farmakologia
• Osasuna

In a note published yesterday, the European Medicines Agency has advised against the use of drugs containing muscle soothing tetrazepam. They have realized that this component can cause serious side effects, especially on the skin, so it is recommended to replace it with other sedatives.

The note details that 13 EU countries sell tetrazepam medicines, including the Basque Country. They are common medicines because they are used to relieve back or neck pain and to treat muscle spasms: Miozepam, Relaxam, Musapam, Myolastan...

Now, however, they have shown that the risk of side effects is greater than the benefit they generate, so they have clearly advised that doctors do not prescribe it and that patients who are using it go to the doctor and consult with him. Moreover, the European Union could suspend the authorization to sell medicines with tetrazepam.

Once there, the French Agency for Medicines and Health Products gave the alarm. In fact, in a study commissioned by him, they saw that tetracepam caused serious skin reactions in some cases. In addition, side effects could not be expected and could appear during or after treatment at normal doses.

At the same time, the European Medicines Agency has announced that although tetracepam is a eve, the rest of the benzodiazepines do not have the same skin reaction capacity. Apparently, this difference is because they have a different structure.